Hurdle
Daniel Elías Martín Herranz is the Co-Founder and CSO of Hurdle since December 2017. Daniel Elías was a PhD Student at EMBL-EBI from October 2015 to April 2019, focusing on the epigenetic aging clock in humans. Daniel Elías was also a Research Intern at the University of Cambridge in the Transmissible Cancer Group, analyzed NGS data of DFTD samples. Furthermore, Daniel Elías served as Treasurer at FEBiotec and participated in projects at ABSal. Daniel also had research internships at Instituto de Biología Funcional y Genómica, Innovagenomics, and NUI Maynooth, specializing in genomics and bioinformatics. Daniel Elías holds a PhD in Biological Sciences from the University of Cambridge, among other degrees.
Hurdle
Hurdle's mission is clear: democratize access to biology for companies and consumers by creating cutting-edge bio-infrastructure. Harnessing deep expertise, our tech-driven platform integrates easily with any business system. With its modular and end-to-end capabilities, Hurdle ensures biology data is not only accessible but also actionable, breaking down the traditional barriers. We're more than just a platform; we're catalysts for change. Through the profound power of biology, we aim to propel businesses and the world into a brighter, more informed future. Whether your goal is boosting revenue, expanding consumer reach, or broadening horizons, Hurdle paves the way with solutions tailored to every challenge. Join us in our journey to unlock biology's untapped potential, empowering organizations with the deep insights they need to thrive. Discover the Hurdle difference at hurdle.bio. Proudly a brand under Chronomics Ltd. Inc.